Liver transplantation

Liver transplantation has been studied in 82 papers since 1997: 1 trial and 52 observational studies in people, 5 in animals, 22 reviews; 27 in the past year. Its furthest trials in people are at phase 3. The newest paper, Nov 7, 2026: “Evolution and impact of sarcopenia and myosteatosis in the context of liver transplantation”.

ExposurePhase 3

82 papers study it38 findingsUpdated

MeSH

Research on it is growing 9% slower than aging research as a whole: 13 papers in the latest year counted

2 new papers in 30 daysSee all 81 papers on liver transplantation

At a glance

Liver transplantation is linked with lower mortality in people with cirrhosis, and independent labs report lower frailty in human recipients. One study reports higher frailty at three months but lower frailty at 12 months; cohorts also link transplantation with higher coronary disease risk. Some papers declare company ties, and an author has a company affiliation.

38 findings in 29 papers from 1997 to 2026, 7 of them since April 2026

Independent labs found the same change in people. 20 independent labs in 13 countries; 9 trials, none about aging, 1 with no results posted.

“The median pretransplant LFI was 3.9, showing minimal change at 3 mo (3.8; P = 0.331) and improvement at 6-mo post-LT (3.6; P = 0.001).”
Frailty Changes After Liver Transplantation. Results From a Spanish Multicenter Prospective Cohort StudyTransplantation direct2024doi:10.1097/txd.0000000000001599

1 of its findings points the other way.

Humans: replicated by independent labs. Mice: a single group. Cells and worms or flies: nothing yet.
  • 20 independent labs in 13 countries
  • 1 finding against
  • 9 trials, none about aging, 1 with no results posted
  • Funders: National Institutes of Health and others
  • 6 of 32 findings with company ties
  • Human trial1
  • Humans52
  • Animals5
  • In silico1

What did studies of liver transplantation find?

19

Studies of liver transplantation measured 19 outcomes, among them frailty, lifespan and survival.

Frailty

downin humans2upin humans1

2 studies
  1. Liver transplantation decreases frailty in humans (post-liver transplantation) (median 3.9 to 3.6, P = 0.001).

    Human trialpost-liver transplantation6 mo

  2. Liver transplantation is linked with lower frailty in humans (median LFI 3.4 at 12 months vs 3.7 pretransplant).

    Humans12 months posttransplantn = 107

  3. Liver transplantation is linked with higher frailty in humans (median LFI 3.7 pretransplant to 3.9 at 3 months).

    Humans3 months posttransplantn = 178

Lifespan

upin humans1upin rats1

2 studies
  1. Liver transplantation increases lifespan in humans (post-liver transplantation).

    Reviewpost-liver transplantation

  2. Liver transplantation extends lifespan in rats (arterialized, orthotopic liver transplantation) (48.1 to 52.4 months).

    Animalsarterialized, orthotopic liver transplantationlivermales

Survival

upin humans1

1 study
  1. Liver transplantation improves survival in humans across full spectrum of frailty severity.

    Reviewacross full spectrum of frailty severity

Pyroptosis

upin mice1

1 study
  1. Liver transplantation increases pyroptosis in mice (aging donor graft versus young graft).

    Animalsaging donor graft versus young graftaging donor graftKupffer cells

More on Pyroptosis

Ischemia-reperfusion injury

upin mice1

1 study
  1. Liver transplantation increases ischemia-reperfusion injury in mice (aging donor graft versus young graft).

    Animalsaging donor graft versus young graftaging donor graftliver

More on Ischemia-reperfusion injury

Biological-age acceleration

no changein humans1

1 study
  1. Liver transplantation was not clearly linked with biological-age acceleration in humans.

    Humanspbmc

More on Biological-age acceleration

Apoptosis

upin rats1

1 study
  1. Liver transplantation increases apoptosis in rats (aged donor grafts).

    Animalsaged donor graftsperibiliary gland

More on Apoptosis

LAMC1

downin rats1

1 study
  1. Liver transplantation decreases LAMC1 in rats (aged donor grafts).

    Animalsaged donor graftsperibiliary gland

More on LAMC1

Cell detachment

upin rats1

1 study
  1. Liver transplantation induces cell detachment in rats (aged donor grafts).

    Animalsaged donor graftsperibiliary gland168 h

Coronary artery calcification

upin humans1

1 study
  1. Liver transplantation is linked with higher coronary artery calcification in liver transplant recipients vs matched controls (26.2% vs. 9.2%, p < 0.0001).

    Humansin liver transplant recipients vs matched controls

All 19

What is liver transplantation linked with?

15

Studies link liver transplantation with 15 measures, among them sarcopenia, cancer and chronic kidney disease.

Sarcopenia

downin humans1mixedin humans1

2 studies
  1. Liver transplantation is associated with sarcopenia in humans (Cirrhotic patients undergoing liver transplantation) (p=0.034).

    HumansCirrhotic patients undergoing liver transplantationskeletal muscle12 months

  2. Sarcopenia is associated with liver transplantation in recipient.

    Reviewin recipientliver

More on Sarcopenia

Cancer

upin humans1+23%

1 study
  1. Liver transplantation is linked with a higher risk of cancer in humans (23%).

    Humans≥30 yn = 138

More on Cancer

Chronic kidney disease

upin humans1+70%

1 study
  1. Liver transplantation is linked with a higher risk of chronic kidney disease in humans (70%).

    Humans≥30 yn = 138

More on Chronic kidney disease

Immune response

upin humans1

1 study
  1. Liver transplantation is associated with immune response in humans (211 DMRs).

    Humanspbmcbetween five and ten years post-transplant

More on Immune response

miRNA expression

mixedin humans1

1 study
  1. Liver transplantation is associated with miRNA expression in humans (regenerating vs nonregenerating phases post-liver transplantation).

    Humansregenerating vs nonregenerating phases post-liver transplantationplasman = 12

More on miRNA expression

SCORE2

no changein humans1

1 study
  1. Liver transplantation is associated with SCORE2 in humans (P = 0.20).

    Humans

More on SCORE2

High-risk plaque

upin humans1OR 2.1

1 study
  1. Liver transplantation is associated with high-risk plaque in humans among individuals with any coronary atherosclerosis (OR: 2.10; 95% CI: 1.29-3.45).

    Humansamong individuals with any coronary atherosclerosis

Coronary atherosclerosis

upin humans1OR 2.19

1 study
  1. Liver transplantation is associated with coronary atherosclerosis in humans (adjusted for age, sex, hypertension, diabetes, dyslipidemia, smoking, and obesity) (OR: 2.19; 95% CI: 1.48-3.27).

    Humansadjusted for age, sex, hypertension, diabetes, dyslipidemia, smoking, and obesity

More on Coronary atherosclerosis

Coronary artery disease

upin humans1

1 study
  1. Liver transplantation is associated with coronary artery disease in humans (Liver transplant recipients compared with population controls) (aHR 2.02, 95% CI 1.80–2.30).

    HumansLiver transplant recipients compared with population controlsMedian follow-up of 8.0 years63% mensn = 2,925

More on Coronary artery disease

Serum and urinary metabolite concentrations

upin humans1

1 study
  1. Liver transplantation is associated with serum and urinary metabolite concentrations in humans After liver transplantation.

    HumansAfter liver transplantationSerum and urine

More on Serum and urinary metabolite concentrations

All 15

Has liver transplantation been tested in people?

0 of 9 about aging

Yes: 1 trial and 52 observational studies in people have been published, and 9 trials are registered.

In trials

All 10

Stopped

Trial sponsors

Funding

12 grants since 2017

National Institute on Aging$10.4MNational Institute of Diabetes and Digestive and Kidney Diseases$2.9MJapan Society for the Promotion of Science¥10.8M

Contains public sector information licensed under the Open Government Licence v3.0.

How this record changed

  1. Summary written from the findings.

Latest

Dec 2025: 2Jan 2026: 6Feb 2026: 3Mar 2026: 5Apr 2026: 1May 2026: 1Jun 2026: 0Jul 2026: 2Aug 2026: 0Sep 2026: 3Oct 2026: 1Nov 2026: 125 papers in 12 months

See all 81 papers on liver transplantation